News
News Center
2020-12-15
As research into the disease mechanisms of stem cell therapy progresses, stem cells have demonstrated promising therapeutic effects across a wide range of medical conditions. Currently, they are already being used to treat more than 200 challenging and complex diseases, offering newfound hope to patients struggling with rare illnesses. Looking ahead, with the continued advancement of regenerative medicine, the clinical translation and implementation of stem cell therapies for diabetes and its associated complications are expected to become a reality sooner rather than later.
+
2020-12-14
CCTV: Stem cell technology helps the "Noodle Brothers" stand tall again.
Twins were diagnosed with the same rare disease, dubbed "Noodle Men," medically known as "Super Cancer," which left them paralyzed at age twelve and ultimately claimed their lives by age eighteen. Their parents embarked on a grueling journey across China, tirelessly searching for a life-saving cure. Thanks to groundbreaking stem-cell therapy, the brothers are now able to walk normally again—giving them a renewed chance at life.
+
2020-12-14
Shenzhen TV and Yishenzen client reporters have just learned from the Standing Committee of the Shenzhen Municipal People's Congress that Shenzhen will take the lead nationwide in enacting legislation to regulate cell and gene therapies!
+
2020-12-08
Jiuzhitang Maker invited to attend the 2nd China Anti-Aging Conference
During the keynote forum's interactive interview session, Dr. Gao Yansong, Vice President of Jiuzhi堂 Group and General Manager of Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd. (hereinafter referred to as Jiuzhitang Maker), delivered a keynote speech titled "Exploring Stem Cell Therapy for COVID-19," sharing with the audience how the century-old Jiuzhi堂 has been actively contributing to the fight against the pandemic.
+
2020-12-01
World AIDS Day | The Complete Process of Stem Cell Therapy for HIV/AIDS
When AIDS is mentioned, many people feel panicked—and some even associate it directly with death. In recent years, the groundbreaking cases of "the Berlin Patient" and "the London Patient," both cured of HIV through stem cell therapy, have captured global attention, offering new hope to AIDS patients while also providing valuable lessons and guidance for future clinical applications of similar treatments. Today, let’s explore together how stem cells are being used to treat HIV/AIDS.
+
2020-11-16
World Diabetes Day | @Diabetes Patients, Confidential Documents Are Ready for Your Review!
Today is World Diabetes Day—let’s talk about diabetes, the flagship "wealth disease."
+
2020-11-05
Join the stroke patient support group and stay updated on stem cell clinical trials!
In February 2020, Jiuzhitang Maker’s clinical trial for a new stem-cell drug received approval—marking the first clinical trial to utilize imported stem cells, the first to target a major neurological indication with stem-cell therapy, and also the first trial approved under the National Medical Products Administration’s resumption of accepting applications for stem-cell clinical trials, specifically one employing bone marrow-derived mesenchymal stem cells. To foster a friendly platform for meaningful exchange, we’ve established a dedicated online community for stroke patients, providing a space where participants can stay updated on stem-cell clinical trial developments, share their medical experiences, and learn from each other’s insights.
+
2020-10-29
What do you know about male menopause?
Research shows that MSCs cultured under normoxic conditions also exhibit some anti-inflammatory regulatory capacity, while itMSCs obtained through hypoxic culture demonstrate even stronger anti-inflammatory abilities. As a result, these hypoxically cultured cells are better equipped to play a crucial role in combating age-related frailty—and hold greater potential to safeguard human health.
+
2020-10-26
In the national quality benchmark selection event organized by China's Ministry of Industry and Information Technology and the China Association for Quality, Jiuzhitang was awarded the title of "2020 National Quality Benchmark."
+
Here is the title—h1 placeholder text
Copyright © Jiuzhitang Maker (Beijing) Cell Technology Co., Ltd.
Powered by: 300.cn SEO | Privacy Policy